SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis-Reference-Cited by-同舟云学术

SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis

Published:2021-08-27 Issue:41 Volume:40 Page:6034-6048
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Tong Kevin,Kothari Om A.,Haro Katherine S.,Panda Anshuman,Bandari Manisha M.,Carrick Jillian N.,Hur Joseph J.,Zhang Lanjing,Chan Chang S.^ORCID,Xing Jinchuan,Gatza Michael L.,Ganesan Shridar,Verzi Michael P.^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Rutgers, The State University of New Jersey

U.S. Department of Defense

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/s41388-021-01997-x.pdf

Reference101 articles.

1. Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, Burt RW, et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol. 2012;107:1315–29.

2. Chouhan H, Sammour T, Thomas ML, Moore JW. Prognostic significance of BRAF mutation alone and in combination with microsatellite instability in stage III colon cancer. Asia Pac J Clin Oncol. 2019;15:69–74.

3. Samowitz WS, Sweeney C, Herrick J, Albertsen H, Levin TR, Murtaugh MA, et al. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res. 2005;65:6063–9.

4. Taieb J, Le Malicot K, Shi Q, Penault-Llorca F, Bouche O, Tabernero J, et al. Prognostic value of BRAF and KRAS mutations in MSI and MSS stage III colon cancer. J Natl Cancer Inst. 2017;109:djw272.

5. Yamane L, Scapulatempo-Neto C, Reis RM, Guimaraes DP. Serrated pathway in colorectal carcinogenesis. World J Gastroenterol. 2014;20:2634–40.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive overview of the molecular features and therapeutic targets in BRAF^V600E‐mutant colorectal cancer;Clinical and Translational Medicine;2024-07

2. FAK loss reduces BRAF^V600E-induced ERK phosphorylation to promote intestinal stemness and cecal tumor formation;ELIFE;2024

3. FAK loss reduces BRAFV600E-induced ERK phosphorylation to promote intestinal stemness and cecal tumor formation;eLife;2024-06-26

4. FAK loss reduces BRAFV600E-induced ERK phosphorylation to promote intestinal stemness and cecal tumor formation;eLife;2024-06-26

5. Dynamic RNA polymerase II occupancy drives differentiation of the intestine under the direction of HNF4;Cell Reports;2024-06